Advertisement

Osteoporosis International

, Volume 28, Issue 9, pp 2737–2738 | Cite as

Statin treatment and healthy adherer effects

  • T. An
  • J. Hao
  • S. Sun
  • R. Li
  • M. Yang
  • G. Cheng
  • M. ZouEmail author
Letter
  • 174 Downloads

Notes

Acknowledgements

This project was supported by grants from the “Faculty of Medical Devices-Jingxin” Cooperation Fund of Shenyang Pharmaceutical University.

Compliance with ethical standards

Conflicts of interest

None.

References

  1. 1.
    Donzelli A, Battaggia A, Schivalocchi A (2017) Statin use does not protect from fractures. The healthy adherer effect is a plausible explanation in observational studies. Osteoporosis Int. doi: 10.1007/s00198-017-4069-1
  2. 2.
    An T, Hao J, Sun S et al (2017) Efficacy of statins for osteoporosis: a systematic review and meta-analysis. Osteoporos Int 28:47–57.Google Scholar
  3. 3.
    Coronary Drug Project Research Group (1980) Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project [J]. N Engl J Med 303(18):1038–1041CrossRefGoogle Scholar
  4. 4.
    Curtis JR, Delzell E, Chen L et al (2011) The relationship between bisphosphonate adherence and fracture: is it the behavior or the medication? Results from the placebo arm of the fracture intervention trial [J]. Journal of Bone & Mineral Research the Official Journal of the American Society for Bone & Mineral Research 26(4):683–688CrossRefGoogle Scholar
  5. 5.
    Ström O, Landfeldt E, Garellick G (2015) Residual effect after oral bisphosphonate treatment and healthy adherer effects-the Swedish adherence register analysis (SARA) [J]. Osteoporos Int 26(1):315–325CrossRefPubMedGoogle Scholar
  6. 6.
    Hollestein L, Baser Ö, Stricker B et al (2015) The healthy user and healthy adherer bias: a nested case–control study among statin users in the Rotterdam Study [J]. Archives of Public Health 73(Suppl 1):O6CrossRefPubMedCentralGoogle Scholar
  7. 7.
    Koçer A, Öner M, Karaman İ et al (2015) The effects of locally applied simvastatin on an experimental mouse femur nonuion model [J]. Acta Orthop Traumatol Turc 48(6):679–684CrossRefGoogle Scholar
  8. 8.
    Rajamannan NM (2015) Atorvastatin attenuates bone loss and aortic valve atheroma in LDLR mice [J]. Cardiology 132(1):11–15CrossRefPubMedGoogle Scholar
  9. 9.
    Issa JP, Ingraci de Lucia C, Dos Santos Kotake BG et al (2015) The effect of simvastatin treatment on bone repair of femoral fracture in animal model [J]. Growth Factors 33(2):139–148CrossRefPubMedGoogle Scholar
  10. 10.
    Kim HB, Myung SK, Park YC et al (2016) Use of benzodiazepine and risk of cancer: a meta-analysis of observational studies [J]. Int J Cancer 140(3):513–525CrossRefPubMedGoogle Scholar
  11. 11.
    Zhao Y, Nicoll R, He YH et al (2016) The effect of statins therapy in aortic stenosis: meta-analysis comparison data of RCTs and observational [J]. Data in Brief 7(C):357CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2017

Authors and Affiliations

  • T. An
    • 1
  • J. Hao
    • 2
  • S. Sun
    • 1
  • R. Li
    • 1
  • M. Yang
    • 1
  • G. Cheng
    • 3
  • M. Zou
    • 3
    Email author
  1. 1.Department of Life Sciences and BiopharmaceuticsShenyang Pharmaceutical UniversityShenyangChina
  2. 2.Department of Blood PurificationGeneral Hospital of Shenyang Military CommandShenyangChina
  3. 3.Department of PharmacyShenyang Pharmaceutical UniversityShenyangChina

Personalised recommendations